Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

The safety and pharmacokinetics of weekly dapsone and weekly dapsone plus pyrimethamine were examined in adult patients with human immunodeficiency virus infection who were at risk for pneumocystis pneumonia because of a prior episode or a CD4+ T-cell count less than 250 cells per mm3. Groups of pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Falloon, J, Lavelle, J, Ogata-Arakaki, D, Byrne, A, Graziani, A, Morgan, A, Amantea, M A, Ownby, K, Polis, M, Davey, R T
Formato: Artigo
Idioma:Inglês
Publicado em: 1994
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC284596/
https://ncbi.nlm.nih.gov/pubmed/7979291
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados